23 research outputs found
<i>Lactobacillus acidophilus</i> attenuated TBI-mediated increase of MLCP.
<p>The interaction of <i>Lactobacillus acidophilus</i> and time on MLCP protein concentrations was not significant. (A) ELISA analysis showed that the concentrations of MLCP in intestinal smooth muscle were significantly increased after TBI, **<i>P</i> < 0.01 compared with control. <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated increase of MLCP, #<i>P</i> < 0.05 compared with TBI. (B) Immunohistochemistry analysis showed that marked increases in MLCP were observed in intestinal smooth muscle after TBI, and treatment with <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated increases of MLCP.</p
Nitrogen Isotope Composition of Thermally Produced NO<sub><i>x</i></sub> from Various Fossil-Fuel Combustion Sources
The nitrogen stable isotope composition
of NO<sub><i>x</i></sub> (δ<sup>15</sup>N-NO<sub><i>x</i></sub>) may
be a useful indicator for NO<sub><i>x</i></sub> source partitioning,
which would help constrain NO<sub><i>x</i></sub> source
contributions in nitrogen deposition studies. However, there is large
uncertainty in the δ<sup>15</sup>N-NO<sub><i>x</i></sub> values for anthropogenic sources other than on-road vehicles
and coal-fired energy generating units. To this end, this study presents
a broad analysis of δ<sup>15</sup>N-NO<sub><i>x</i></sub> from several fossil-fuel combustion sources that includes:
airplanes, gasoline-powered vehicles not equipped with a three-way
catalytic converter, lawn equipment, utility vehicles, urban buses,
semitrucks, residential gas furnaces, and natural-gas-fired power
plants. A relatively large range of δ<sup>15</sup>N-NO<sub><i>x</i></sub> values was measured from −28.1‰ to
8.5‰ for individual exhaust/flue samples that generally tended
to be negative due to the kinetic isotope effect associated with thermal
NO<sub><i>x</i></sub> production. A negative correlation
between NO<sub><i>x</i></sub> concentrations and δ<sup>15</sup>N-NO<sub><i>x</i></sub> for fossil-fuel combustion
sources equipped with selective catalytic reducers was observed, suggesting
that the catalytic reduction of NO<sub><i>x</i></sub> increases
δ<sup>15</sup>N-NO<sub><i>x</i></sub> values relative
to the NO<sub><i>x</i></sub> produced through fossil-fuel
combustion processes. Combining the δ<sup>15</sup>N-NO<sub><i>x</i></sub> measured in this study with previous published values,
a δ<sup>15</sup>N-NO<sub><i>x</i></sub> regional and
seasonal isoscape was constructed for the contiguous U.S., which demonstrates
seasonal and regional importance of various NO<sub><i>x</i></sub> sources
<i>P</i>-values of a two-way ANOVA for the effects of <i>Lactobacillus acidophilus</i>, time, and their interactions on the ten variables (N = 90).
<p>Note: MLCK: myosin light chain kinase; MLCP: myosin light chain phosphatase; PKC: protein kinase C; ICC numbers: the numbers of interstitial cells of Cajal.</p><p>*indicates a significant difference (<i>P</i> < 0.05)</p><p>**indicates a highly significant difference (<i>P</i> < 0.01).</p><p><i>P</i>-values of a two-way ANOVA for the effects of <i>Lactobacillus acidophilus</i>, time, and their interactions on the ten variables (N = 90).</p
<i>Lactobacillus acidophilus</i> restored the impaired ICC networks mediated by TBI.
<p>The ICC networks and numbers were detected under fluorescence microscope (400×) by immunofluorescence in ileal tissue sections. The interaction of <i>Lactobacillus acidophilus</i> and time on ICC numbers was not significant. (A) Low-density of ICC networks was observed after TBI compared with control. <i>Lactobacillus acidophilus</i> significantly restored TBI-mediated disruption of ICC networks. (B) The reduction of ICC numbers was also observed after TBI, **<i>P</i> < 0.01 compared with control. <i>Lactobacillus acidophilus</i> significantly restored TBI-mediated reduction of ICC numbers, #<i>P</i> < 0.05 compared with TBI.</p
Standardized Iterative Genome Editing Method for Escherichia coli Based on CRISPR-Cas9
The
introduction of complex biosynthetic pathways into
the hosts’
chromosomes is gaining attention with the development of synthetic
biology. While CRISPR-Cas9 has been widely employed for gene knock-in,
the process of multigene insertion remains cumbersome due to laborious
and empirical gene cloning procedures. To address this, we devised
a standardized iterative genome editing system for Escherichia coli, harnessing the power of CRISPR-Cas9
and MetClo assembly. This comprehensive toolkit comprises two fundamental
elements based on the Golden Gate standard for modular assembly of
sgRNA or CRISPR arrays and donor DNAs. We achieved a gene insertion
efficiency of up to 100%, targeting a single locus. Expression of
tracrRNA using a strong promoter enhances multiplex genomic insertion
efficiency to 7.3%, compared with 0.76% when a native promoter is
used. To demonstrate the robust capabilities of this genome editing
toolbox, we successfully integrated 5–10 genes from the coenzyme
B12 biosynthetic pathway ranging from 5.3 to 8 Kb in length
into the chromosome of E. coli chassis
cells, resulting in 14 antibiotic-free, plasmid-free producers. Following
an extensive screening process involving genes from diverse sources,
cistronic design modifications, and chromosome repositioning, we obtained
a recombinant strain yielding 1.49 mg L–1 coenzyme
B12, the highest known titer achieved by using E. coli as the producer. Illuminating its user-friendliness,
this genome editing system is an exceedingly versatile tool for expediently
integrating complex biosynthetic pathway genes into hosts’
genomes, thus facilitating pathway optimization for chemical production
<i>Lactobacillus acidophilus</i> improved the morphology of villus.
<p>The intestinal sections from control mice presented intact structures with complete intestinal mucosae and villi (3A, 3D and 3G). TBI caused abnormal intestinal wall morphology and damaged the intestinal villi and structural integrity (3B, 3E and 3H). <i>Lactobacillus acidophilus</i> recovered intestinal mucosae and restructured villi (3C, 3F and 3I).</p
<i>Lactobacillus acidophilus</i> attenuated TBI-mediated decrease in levels of phospho-MYPT1 and increases in PKC protein concentrations.
<p>The interaction of <i>Lactobacillus acidophilus</i> and time on phospho-MYPT1 concentrations was not significant. (A and B) A marked decreases in phospho-MYPT1 were observed in intestinal smooth muscle after TBI, **<i>P</i> < 0.01 compared with control. Treatment with <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated inhibition of MYPT1 phosphorylation, ##<i>P</i> < 0.01 compared with TBI. The interaction of <i>Lactobacillus acidophilus</i> and time on PKC protein concentrations was significant. (C) ELISA analysis showed that the concentrations of PKC were increased in intestinal smooth muscle after TBI, *<i>P</i> < 0.05 compared with control. <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated induction of PKC protein concentrations, #<i>P</i> < 0.05 compared with TBI.</p
<i>Lactobacillus acidophilus</i> improved the contractile activity of intestinal smooth muscle impaired by TBI.
<p>Ninety C57BL/6 mice were randomly divided into three groups including control, TBI and TBI + <i>Lactobacillus acidophilus</i> groups. The interaction of <i>Lactobacillus acidophilus</i> and time on intestinal contractile activity was not significant. (A) The contractile activity was determined by histologic and physiologic analyses. (B) The average contractile amplitude was decreased after TBI, **<i>P</i> < 0.01 compared with control. <i>Lactobacillus acidophilus</i> could increase in contractile amplitude, #<i>P</i> < 0.05 compared with TBI. (C and D) The contractile frequency and tension were also decreased after TBI, **<i>P</i> < 0.01 compared with control. <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated decreases of contractile frequency and tension, #<i>P</i> < 0.05 compared with TBI. (E) The intestinal transit rate was decreased after TBI, **<i>P</i> < 0.01 compared with control. <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated decrease of intestinal transit rate, ##<i>P</i> < 0.01 compared with TBI.</p
<i>Lactobacillus acidophilus</i> attenuated TBI-mediated reduction of MLCK.
<p>The interaction of <i>Lactobacillus acidophilus</i> and time on MLCK protein concentrations was not significant. (A) ELISA analysis showed that the concentrations of MLCK in intestinal smooth muscle were significantly decreased after TBI, *<i>P</i> < 0.05 compared with control. <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated reduction of MLCK concentrations, ##<i>P</i> < 0.01 compared with TBI. (B) Immunohistochemistry analysis showed that marked decreases in MLCK were observed in intestinal smooth muscle after TBI, and treatment with <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated inhibition of MLCK.</p
<i>Lactobacillus acidophilus</i> could increase the MLC<sub>20</sub> phosphorylation.
<p>The interaction of <i>Lactobacillus acidophilus</i> and time on MLC<sub>20</sub> phosphorylation was not significant. (A and B) The levels of phospho-MLC<sub>20</sub> in intestinal smooth muscle were significantly decreased after TBI, *<i>P</i> < 0.05 compared with control. Treating with <i>Lactobacillus acidophilus</i> attenuated TBI-mediated inhibition of MLC<sub>20</sub> phosphorylation, #<i>P</i> < 0.05 compared with TBI. (C) The marked decreases in immunoreactivity for phospho-MLC<sub>20</sub> were observed in intestinal smooth muscle after TBI, and treatment with <i>Lactobacillus acidophilus</i> significantly attenuated TBI-mediated inhibition of MLC<sub>20</sub> phosphorylation.</p